Applicant Arguments on the USPTO non-final rejection of the “NGAL exclusion patent” application. (Page 1)

By On 5. June 2012 · Leave a Comment · In BioPorto

About Karl M. Bidstrup

Tidligere ejer af Medicoinvestor.com Strategien har gennem mange år været at profitere på etablerede aktier, og brænde det hele af på Bioporto... Sad but true. Kontakt mig på medicoinvestor(A)gmail.com hvis du har en million du ikke ved hvor du skal gemme, så skal jeg nok holde den for dig. 🙂

Related posts:

  1. Amended APC-PCI application Bioporto and their patent advisor Høiberg has filed an amended...
  2. Spectrum Chart If you look at my chart on SPPI you can...
  3. APC-PCI patent – status at EPO/USPTO Some have described BioPorto as a “one trick pony” –...
  4. Spectrum Chart update The important thing to notice here is the green...
  5. Spectrum chart Man kan tage et kigge på chartet og se...
 

Leave a Reply

Your email address will not be published. Required fields are marked *

Set your Twitter account name in your settings to use the TwitterBar Section.